Rhonda Patrick· PhD
sulforaphane actually inhibits the NF-kappaB pathway, which is one of the main inflammatory pathways in the body.
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
sulforaphane actually inhibits the NF-kappaB pathway, which is one of the main inflammatory pathways in the body.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
You know, and that's, of course, where sulforaphane shines. You know, I mean, it's inhibiting NF-KappaB pathway, like you said, activating all these anti-inflammatory pathways.
Sulfurophane has been shown in mice to inhibit NFCAPPA B through the activation of NRF2.